Parents in Treatment in Germany 2010

"A total of N=11,627 persons receiving supervision/assistance or undergoing treatment live in the same household with at least one child. The largest group of clients (principal diagnosis opioids) are the group living with at least one child in a household (n=7,465, 17.4%) (see Table 12.3). Clients with a principal diagnosis of cannabis compose the second largest group of clients and also the second largest group living with children in the same household (n=2,340). With other principal diagnoses the figure is 17.1% (n=781) for persons with a principal diagnosis of cocaine, 15.3% (n=713) for persons with a principal diagnosis of stimulants and 20.5% (n=317) for persons with a principal diagnosis of sedatives/hypnotics. With all main diagnoses, more than half of the clients living in a household with children live with one child and more than one-fourth with two children in the same household. (see Table 12.3).
"The majority of clients at ambulatory facilities do not live alone. Out of the total principal diagnosis, the persons not living alone account for between 58.5% (principal diagnosis opioids) and 62.1% (principal diagnosis stimulants). Among these the percentage of persons who live with children varies considerably. While somewhat more than one in every ten clients not living alone with a principal diagnosis of cannabis lives with children (11.0%), among persons with a principal diagnosis of stimulants this figure is almost one in every five (18.2%). The figure for persons with a principal diagnosis of cocaine is 22.8% and a principal diagnosis of opioids is 25.0%. The share among persons with a principal diagnosis of sedatives/hypnotics is even more than one in every three at 36.9% (see Table 12.5)."

Source

2011 National Report to the EMCDDA by the Reitox National Focal Point: Germany: New Developments, Trends and In-Depth Information on Selected Issues - Drug Situation 2010/2011" (German Reference Centre for the European Monitoring Centre for Drugs and Drug Addiction (Deutsche Beobachtungsstelle fuer Drogen und Drogensucht, DBDD), the Institute for Therapy Research (Institut fuer Therapieforschung, IFT), the Federal Centre for Health Education (Bundeszentrale fuer gesundheitliche Aufklaerung, BZgA) and the German Centre for Addiction Issues (Deutsche Hauptstelle fuer Suchtfragen, DHS)), (Lisbon, Portugal: EMCDDA, Nov. 2012), p. 248.
http://www.emcdda.europa.eu/a…